Which has better earnings & valuation, SHC or MEDP?

Medpace has higher revenue and earnings than Sotera Health. Sotera Health is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Sotera Health $1.16B 4.78 $77.94M $0.57 34.17 Medpace $2.53B 6.74 $451.12M $17.06 35.80

Is SHC or MEDP more profitable?

Medpace has a net margin of 17.67% compared to Sotera Health's net margin of 13.44%. Medpace's return on equity of 110.15% beat Sotera Health's return on equity. Company Net Margins Return on Equity Return on Assets Sotera Health 13.44% 40.12% 7.55% Medpace 17.67% 110.15% 24.84%

Does the media refer more to SHC or MEDP?

In the previous week, Medpace had 26 more articles in the media than Sotera Health. MarketBeat recorded 36 mentions for Medpace and 10 mentions for Sotera Health. Medpace's average media sentiment score of 1.06 beat Sotera Health's score of 0.63 indicating that Medpace is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sotera Health 6 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Medpace 27 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer CRL or SHC?

In the previous week, Charles River Laboratories International and Charles River Laboratories International both had 10 articles in the media. Sotera Health's average media sentiment score of 0.63 beat Charles River Laboratories International's score of 0.49 indicating that Sotera Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Charles River Laboratories International 5 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Sotera Health 6 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings and valuation, ICLR or SHC?

Icon has higher revenue and earnings than Sotera Health. Sotera Health is trading at a lower price-to-earnings ratio than Icon, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Icon $8.25B 1.56 $229.34M $4.26 39.51 Sotera Health $1.16B 4.78 $77.94M $0.57 34.17

Is ICLR or SHC more profitable?

Sotera Health has a net margin of 13.44% compared to Icon's net margin of 3.99%. Sotera Health's return on equity of 40.12% beat Icon's return on equity. Company Net Margins Return on Equity Return on Assets Icon 3.99% 8.02% 4.56% Sotera Health 13.44% 40.12% 7.55%

Does the media refer more to ICLR or SHC?

In the previous week, Sotera Health had 5 more articles in the media than Icon. MarketBeat recorded 10 mentions for Sotera Health and 5 mentions for Icon. Icon's average media sentiment score of 0.98 beat Sotera Health's score of 0.63 indicating that Icon is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Icon 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sotera Health 6 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better valuation and earnings, RVTY or SHC?

Revvity has higher revenue and earnings than Sotera Health. Sotera Health is trading at a lower price-to-earnings ratio than Revvity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Revvity $2.91B 4.78 $241.20M $2.10 59.34 Sotera Health $1.16B 4.78 $77.94M $0.57 34.17

Is RVTY or SHC more profitable?

Sotera Health has a net margin of 13.44% compared to Revvity's net margin of 8.16%. Sotera Health's return on equity of 40.12% beat Revvity's return on equity. Company Net Margins Return on Equity Return on Assets Revvity 8.16% 8.34% 5.01% Sotera Health 13.44% 40.12% 7.55%

Does the media favor RVTY or SHC?

In the previous week, Revvity had 4 more articles in the media than Sotera Health. MarketBeat recorded 14 mentions for Revvity and 10 mentions for Sotera Health. Revvity's average media sentiment score of 1.20 beat Sotera Health's score of 0.63 indicating that Revvity is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Revvity 11 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sotera Health 6 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings & valuation, TECH or SHC?

Bio-Techne has higher revenue and earnings than Sotera Health. Sotera Health is trading at a lower price-to-earnings ratio than Bio-Techne, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Bio-Techne $1.22B 9.33 $181.86M $1.15 62.90 Sotera Health $1.16B 4.78 $77.94M $0.57 34.17

Is TECH or SHC more profitable?

Bio-Techne has a net margin of 14.97% compared to Sotera Health's net margin of 13.44%. Sotera Health's return on equity of 40.12% beat Bio-Techne's return on equity. Company Net Margins Return on Equity Return on Assets Bio-Techne 14.97% 13.23% 10.61% Sotera Health 13.44% 40.12% 7.55%

Does the media prefer TECH or SHC?

In the previous week, Bio-Techne had 8 more articles in the media than Sotera Health. MarketBeat recorded 18 mentions for Bio-Techne and 10 mentions for Sotera Health. Bio-Techne's average media sentiment score of 1.40 beat Sotera Health's score of 0.63 indicating that Bio-Techne is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bio-Techne 15 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sotera Health 6 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Sotera Health (SHC) Competitors

$19.50 +0.33 (+1.70%)

As of 03:49 PM Eastern

Compare

SHC vs. MEDP, CRL, ICLR, RVTY, and TECH

Should you buy Sotera Health stock or one of its competitors? Sotera Health's main competitors and comparable companies include Medpace (MEDP), Charles River Laboratories International (CRL), Icon (ICLR), Revvity (RVTY), and Bio-Techne (TECH). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "life sciences tools & services" industry.

How does Sotera Health compare to Medpace?

Sotera Health (NASDAQ:SHC) and Medpace (NASDAQ:MEDP) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, media sentiment, earnings, risk, institutional ownership and valuation.

Medpace has higher revenue and earnings than Sotera Health. Sotera Health is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sotera Health	$1.16B	4.78	$77.94M	$0.57	34.17
Medpace	$2.53B	6.74	$451.12M	$17.06	35.80

Sotera Health currently has a consensus price target of $21.50, indicating a potential upside of 10.39%. Medpace has a consensus price target of $584.18, indicating a potential downside of 4.35%. Given Sotera Health's stronger consensus rating and higher possible upside, analysts plainly believe Sotera Health is more favorable than Medpace.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73
Medpace	0 Sell rating(s)	10 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.23

Medpace has a net margin of 17.67% compared to Sotera Health's net margin of 13.44%. Medpace's return on equity of 110.15% beat Sotera Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sotera Health	13.44%	40.12%	7.55%
Medpace	17.67%	110.15%	24.84%

Sotera Health has a beta of 1.77, indicating that its share price is 77% more volatile than the broader market. Comparatively, Medpace has a beta of 1.15, indicating that its share price is 15% more volatile than the broader market.

91.0% of Sotera Health shares are held by institutional investors. Comparatively, 78.0% of Medpace shares are held by institutional investors. 15.4% of Sotera Health shares are held by insiders. Comparatively, 20.5% of Medpace shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, Medpace had 26 more articles in the media than Sotera Health. MarketBeat recorded 36 mentions for Medpace and 10 mentions for Sotera Health. Medpace's average media sentiment score of 1.06 beat Sotera Health's score of 0.63 indicating that Medpace is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sotera Health	6 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Medpace	27 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Medpace beats Sotera Health on 11 of the 16 factors compared between the two stocks.

How does Sotera Health compare to Charles River Laboratories International?

Charles River Laboratories International (NYSE:CRL) and Sotera Health (NASDAQ:SHC) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, earnings, risk, valuation, institutional ownership and profitability.

Sotera Health has a net margin of 13.44% compared to Charles River Laboratories International's net margin of -5.96%. Sotera Health's return on equity of 40.12% beat Charles River Laboratories International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Charles River Laboratories International	-5.96%	15.75%	6.51%
Sotera Health	13.44%	40.12%	7.55%

Charles River Laboratories International has a beta of 1.38, suggesting that its stock price is 38% more volatile than the broader market. Comparatively, Sotera Health has a beta of 1.77, suggesting that its stock price is 77% more volatile than the broader market.

Sotera Health has lower revenue, but higher earnings than Charles River Laboratories International. Charles River Laboratories International is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Charles River Laboratories International	$4.02B	3.55	-$144.34M	-$4.85	N/A
Sotera Health	$1.16B	4.78	$77.94M	$0.57	34.17

Charles River Laboratories International currently has a consensus price target of $255.65, suggesting a potential downside of 14.30%. Sotera Health has a consensus price target of $21.50, suggesting a potential upside of 10.39%. Given Sotera Health's stronger consensus rating and higher possible upside, analysts clearly believe Sotera Health is more favorable than Charles River Laboratories International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Charles River Laboratories International	1 Sell rating(s)	3 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.69
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73

98.9% of Charles River Laboratories International shares are held by institutional investors. Comparatively, 91.0% of Sotera Health shares are held by institutional investors. 1.3% of Charles River Laboratories International shares are held by insiders. Comparatively, 15.4% of Sotera Health shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Charles River Laboratories International and Charles River Laboratories International both had 10 articles in the media. Sotera Health's average media sentiment score of 0.63 beat Charles River Laboratories International's score of 0.49 indicating that Sotera Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Charles River Laboratories International	5 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Sotera Health	6 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Sotera Health beats Charles River Laboratories International on 12 of the 15 factors compared between the two stocks.

How does Sotera Health compare to Icon?

Icon (NASDAQ:ICLR) and Sotera Health (NASDAQ:SHC) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, valuation, institutional ownership, earnings, media sentiment, dividends, profitability and analyst recommendations.

Icon presently has a consensus price target of $170.40, indicating a potential upside of 1.25%. Sotera Health has a consensus price target of $21.50, indicating a potential upside of 10.39%. Given Sotera Health's stronger consensus rating and higher probable upside, analysts clearly believe Sotera Health is more favorable than Icon.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Icon	2 Sell rating(s)	7 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.41
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73

In the previous week, Sotera Health had 5 more articles in the media than Icon. MarketBeat recorded 10 mentions for Sotera Health and 5 mentions for Icon. Icon's average media sentiment score of 0.98 beat Sotera Health's score of 0.63 indicating that Icon is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Icon	3 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Sotera Health	6 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Icon has a beta of 1.21, meaning that its stock price is 21% more volatile than the broader market. Comparatively, Sotera Health has a beta of 1.77, meaning that its stock price is 77% more volatile than the broader market.

95.6% of Icon shares are held by institutional investors. Comparatively, 91.0% of Sotera Health shares are held by institutional investors. 44.0% of Icon shares are held by company insiders. Comparatively, 15.4% of Sotera Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Sotera Health has a net margin of 13.44% compared to Icon's net margin of 3.99%. Sotera Health's return on equity of 40.12% beat Icon's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Icon	3.99%	8.02%	4.56%
Sotera Health	13.44%	40.12%	7.55%

Icon has higher revenue and earnings than Sotera Health. Sotera Health is trading at a lower price-to-earnings ratio than Icon, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Icon	$8.25B	1.56	$229.34M	$4.26	39.51
Sotera Health	$1.16B	4.78	$77.94M	$0.57	34.17

Summary

Sotera Health beats Icon on 9 of the 17 factors compared between the two stocks.

How does Sotera Health compare to Revvity?

Revvity (NYSE:RVTY) and Sotera Health (NASDAQ:SHC) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, media sentiment, risk, analyst recommendations, earnings, institutional ownership, valuation and dividends.

Sotera Health has a net margin of 13.44% compared to Revvity's net margin of 8.16%. Sotera Health's return on equity of 40.12% beat Revvity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Revvity	8.16%	8.34%	5.01%
Sotera Health	13.44%	40.12%	7.55%

Revvity has a beta of 1.07, indicating that its stock price is 7% more volatile than the broader market. Comparatively, Sotera Health has a beta of 1.77, indicating that its stock price is 77% more volatile than the broader market.

86.7% of Revvity shares are held by institutional investors. Comparatively, 91.0% of Sotera Health shares are held by institutional investors. 0.9% of Revvity shares are held by company insiders. Comparatively, 15.4% of Sotera Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Revvity has higher revenue and earnings than Sotera Health. Sotera Health is trading at a lower price-to-earnings ratio than Revvity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Revvity	$2.91B	4.78	$241.20M	$2.10	59.34
Sotera Health	$1.16B	4.78	$77.94M	$0.57	34.17

In the previous week, Revvity had 4 more articles in the media than Sotera Health. MarketBeat recorded 14 mentions for Revvity and 10 mentions for Sotera Health. Revvity's average media sentiment score of 1.20 beat Sotera Health's score of 0.63 indicating that Revvity is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Revvity	11 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Sotera Health	6 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Revvity currently has a consensus target price of $108.36, suggesting a potential downside of 13.04%. Sotera Health has a consensus target price of $21.50, suggesting a potential upside of 10.39%. Given Sotera Health's stronger consensus rating and higher possible upside, analysts clearly believe Sotera Health is more favorable than Revvity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Revvity	0 Sell rating(s)	12 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.20
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73

Summary

Sotera Health beats Revvity on 10 of the 16 factors compared between the two stocks.

How does Sotera Health compare to Bio-Techne?

Bio-Techne (NASDAQ:TECH) and Sotera Health (NASDAQ:SHC) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, risk, earnings, profitability, valuation, dividends and institutional ownership.

Bio-Techne currently has a consensus price target of $68.92, suggesting a potential downside of 4.72%. Sotera Health has a consensus price target of $21.50, suggesting a potential upside of 10.39%. Given Sotera Health's stronger consensus rating and higher probable upside, analysts clearly believe Sotera Health is more favorable than Bio-Techne.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bio-Techne	1 Sell rating(s)	14 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.06
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73

Bio-Techne has a net margin of 14.97% compared to Sotera Health's net margin of 13.44%. Sotera Health's return on equity of 40.12% beat Bio-Techne's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bio-Techne	14.97%	13.23%	10.61%
Sotera Health	13.44%	40.12%	7.55%

99.0% of Bio-Techne shares are owned by institutional investors. Comparatively, 91.0% of Sotera Health shares are owned by institutional investors. 1.3% of Bio-Techne shares are owned by insiders. Comparatively, 15.4% of Sotera Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Bio-Techne has higher revenue and earnings than Sotera Health. Sotera Health is trading at a lower price-to-earnings ratio than Bio-Techne, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bio-Techne	$1.22B	9.33	$181.86M	$1.15	62.90
Sotera Health	$1.16B	4.78	$77.94M	$0.57	34.17

In the previous week, Bio-Techne had 8 more articles in the media than Sotera Health. MarketBeat recorded 18 mentions for Bio-Techne and 10 mentions for Sotera Health. Bio-Techne's average media sentiment score of 1.40 beat Sotera Health's score of 0.63 indicating that Bio-Techne is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bio-Techne	15 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Sotera Health	6 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Bio-Techne has a beta of 1.28, meaning that its stock price is 28% more volatile than the broader market. Comparatively, Sotera Health has a beta of 1.77, meaning that its stock price is 77% more volatile than the broader market.

Summary

Bio-Techne beats Sotera Health on 10 of the 16 factors compared between the two stocks.

Get Sotera Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SHC vs. The Competition

Export

Metric	Sotera Health	Life Sciences Tools & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$5.55B	$10.06B	$7.32B	$12.76B
Dividend Yield	N/A	1.46%	2.54%	10.78%
P/E Ratio	34.11	63.35	271.20	24.17
Price / Sales	4.78	109.25	696.57	128.56
Price / Cash	15.32	27.04	29.03	36.89
Price / Book	9.14	5.68	11.33	6.51
Net Income	$77.94M	$56.67B	$3.46B	$347.63M
7 Day Performance	5.22%	5.15%	3.12%	1.53%
1 Month Performance	12.26%	10.51%	8.67%	5.17%
1 Year Performance	18.83%	26.54%	27.37%	17.69%

Sotera Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SHC Sotera Health	3.6679 of 5 stars	$19.48 +1.6%	$21.50 +10.4%	+16.7%	$5.55B	$1.16B	34.11	3,000
MEDP Medpace	3.5229 of 5 stars	$591.68 -0.9%	$584.18 -1.3%	+33.7%	$16.49B	$2.53B	34.63	6,200	Positive News Insider Trade
CRL Charles River Laboratories International	1.8633 of 5 stars	$280.44 -2.2%	$255.65 -8.8%	+84.9%	$13.39B	$4.00B	N/A	19,700
ICLR Icon	3.2927 of 5 stars	$169.47 +0.0%	$170.40 +0.6%	-1.3%	$12.97B	$8.29B	39.78	40,100
RVTY Revvity	3.3599 of 5 stars	$114.77 -1.2%	$108.36 -5.6%	+30.9%	$12.81B	$2.86B	54.65	11,000	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SHC) was last updated on 8/25/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Sotera Health (SHC) Competitors

SHC vs. MEDP, CRL, ICLR, RVTY, and TECH

How does Sotera Health compare to Medpace?

Summary

How does Sotera Health compare to Charles River Laboratories International?

Summary

How does Sotera Health compare to Icon?

Summary

How does Sotera Health compare to Revvity?

Summary

How does Sotera Health compare to Bio-Techne?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SHC vs. The Competition

Sotera Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Sotera Health (SHC) Competitors

SHC vs. MEDP, CRL, ICLR, RVTY, and TECH

How does Sotera Health compare to Medpace?

Which has better earnings & valuation, SHC or MEDP?

Do analysts prefer SHC or MEDP?

Is SHC or MEDP more profitable?

Which has more volatility & risk, SHC or MEDP?

Do institutionals and insiders have more ownership in SHC or MEDP?

Does the media refer more to SHC or MEDP?

Summary

How does Sotera Health compare to Charles River Laboratories International?

Is CRL or SHC more profitable?

Which has more volatility and risk, CRL or SHC?

Which has preferable valuation & earnings, CRL or SHC?

Do analysts recommend CRL or SHC?

Do institutionals and insiders hold more shares of CRL or SHC?

Does the media prefer CRL or SHC?

Summary

How does Sotera Health compare to Icon?

Do analysts prefer ICLR or SHC?

Does the media refer more to ICLR or SHC?

Which has more volatility and risk, ICLR or SHC?

Do institutionals and insiders believe in ICLR or SHC?

Is ICLR or SHC more profitable?

Which has higher earnings and valuation, ICLR or SHC?

Summary

How does Sotera Health compare to Revvity?

Is RVTY or SHC more profitable?

Which has more risk & volatility, RVTY or SHC?

Do institutionals & insiders hold more shares of RVTY or SHC?

Which has better valuation and earnings, RVTY or SHC?

Does the media favor RVTY or SHC?

Do analysts rate RVTY or SHC?

Summary

How does Sotera Health compare to Bio-Techne?

Do analysts recommend TECH or SHC?

Is TECH or SHC more profitable?

Do insiders & institutionals hold more shares of TECH or SHC?

Which has better earnings & valuation, TECH or SHC?

Does the media prefer TECH or SHC?

Which has more volatility and risk, TECH or SHC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SHC vs. The Competition

Sotera Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools